As an important strategic layout of Tat Ka Wai Hong in the field of life and health, the Tat Ka Wai Hong Institute of Regenerative Medicine is committed to combining breakthroughs in key core technologies with solutions to clinical applications, focusing on the research and development of internationally leading cell medicine research and development technologies, cell storage technologies, cell quality detection technologies, cell transplantation and treatment technologies, etc., comprehensively promoting the development of innovative technologies and new medical products in the field of stem cells, and striving to create a regenerative medicine innovation platform that integrates regenerative medicine research and development, achievement transformation, industry incubation, and technical services, leading the high-quality development of the regenerative medicine industry.

The Tat Ka Wai Hong Regenerative Medicine Clinical Trial Research Center targets the actual needs of the medical industry and is committed to conducting clinical trials of new drugs and their derivative products in the field of stem cells to ensure the safety and effectiveness of drugs and medical technologies, and strives to transform major discoveries and technological research results of basic research into drugs, pharmaceutical intermediates and medical devices, providing a series of medical services such as diagnosis, comprehensive treatment, personalized health care, etc. for the majority of patients and customers, such as stem cell treatment of infertility, nervous system, cardiovascular diseases, stem cell anti-aging, stem cell medical beauty, etc.